TATVA vs VIDHIING: Stock Comparison
TATVA CHIN PHARM CHEM is the larger company by market capitalisation. TATVA CHIN PHARM CHEM shows faster revenue growth and lower leverage, while VIDHI SPCLTY F INGRDNTS L shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
TATVA leads 5; VIDHIING leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | TATVA | VIDHIING |
|---|---|---|
| Sector | Chemicals | Chemicals |
| Industry | Specialty Chemicals | Specialty Chemicals |
Price
| Metric | TATVA | VIDHIING |
|---|---|---|
| Live Price | ₹1,608.7 | ₹334.45 |
| Day Change | -3.04% | -1.31% |
| Volume | 47,765 | 17,238 |
| 52-Week High | ₹1,838.1 | ₹387.85 |
| 52-Week Low | ₹981.5 | ₹258.6 |
| Distance from 52W High | -12.48% | -13.77% |
Valuation
| Metric | TATVA | VIDHIING |
|---|---|---|
| Market Cap | ₹3,756 Cr | ₹1,668 Cr |
| P/E Ratio | 73.08x | 31.89x |
| P/B Ratio | 4.8x | 5.18x |
| EPS | ₹4.47 | ₹3.43 |
| Book Value | ₹334.2 | ₹65.64 |
| Dividend Yield | 0.12% | 0.9% |
Growth
| Metric | TATVA | VIDHIING |
|---|---|---|
| Revenue Growth (TTM YoY) | 24.4% | 12% |
| EPS Growth (TTM YoY) | 907.5% | 11.4% |
| Qtr Sales Growth | -12.18% | 0% |
| Qtr Profit Growth | -34.63% | 0.08% |
Profitability & Leverage
| Metric | TATVA | VIDHIING |
|---|---|---|
| ROE | 5.38% | 14.94% |
| ROCE | 4.93% | 14.05% |
| Net Margin | 8.31% | 12.85% |
| Operating Margin | 11.83% | 18.62% |
| Debt to Equity | 0.15x | 0.18x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | TATVA | VIDHIING |
|---|---|---|
| Promoter Holding | 72.02% | 64.27% |
| FII Holding | 3.93%▲ 0.11 pp | 0.07%▼ 0.05 pp |
| DII Holding | 3.11%▲ 0.12 pp | 0.04%▲ 0.04 pp |
| Public Holding | 20.94%▼ 0.23 pp | 35.62%▲ 0.01 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: TATVA CHIN PHARM CHEM and VIDHI SPCLTY F INGRDNTS L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.